REPROGRAMACIÓN Y REGENERACIÓN NEURAL
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (6)
2024
-
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Neuron, Vol. 112, Núm. 17, pp. 2886-2909.e16
2019
-
Successful development and clinical translation of a novel anterior lamellar artificial cornea
Journal of Tissue Engineering and Regenerative Medicine, Vol. 13, Núm. 12, pp. 2142-2154
2009
-
Stem cells and cell replacement therapy for Parkinson's disease
Journal of Neural Transmission, Supplementa, pp. 287-299
2008
-
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism
Neurobiology of Disease, Vol. 30, Núm. 3, pp. 430-438
2007
-
Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations
Stem Cells, Vol. 25, Núm. 9, pp. 2257-2268
2005
-
Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients
Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics (Cambridge University Press), pp. 363-380